Clinical Trial

PTC-guided Neoadjuvant Therapy For Muscle-invasive Bladder Cancer

Name: PTC-guided Neoadjuvant Therapy For Muscle-invasive Bladder Cancer — clinical trial record (NCT07690878)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This study evaluates Patient-derived Tumor-like Cell Clusters (PTC)-guided individualized neoadjuvant therapy in patients with muscle-invasive bladder cancer who are candidates for radical cystectomy.

Trial Details

NCT Number	NCT07690878
Lead Sponsor	The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Conditions	Bladder Cancer
Enrollment	35 participants
Start Date	2026-07
Primary Completion	2027-10 (estimated)
Study Completion	2028-10 (estimated)
Updated on ClinicalTrials.gov	2026-07-08